FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 325:1063-1066 October 10, 1991 Number 15 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

BACKGROUND. Lupus anticoagulants and anticardiolipin antibodies are antiphospholipid antibodies that have been associated with fetal loss, but they have not been shown unequivocally to be a risk factor for this event. METHODS. To estimate the risk of fetal loss in association with these antibodies, we conducted a hospital-based case-control study of 331 women with spontaneous abortion or fetal death (case patients) and 993 controls. The subjects were included in the study only if they reported that they had had no previous spontaneous fetal loss. Each control was a pregnant woman who, in the same period of pregnancy as a case patient, had not had a fetal loss. Lupus anticoagulants were identified in blood samples through a series of coagulation tests, and IgG anticardiolipins by an enzyme-linked immunosorbent assay. Each subject was interviewed in person to obtain information on potential confounding variables, such as sociodemographic characteristics and medical conditions. RESULTS. Lupus anticoagulants were found in blood from 17 case patients (5.1 percent) and 38 controls (3.8 percent). The crude odds ratio for the association between lupus anticoagulants and fetal loss was 1.36 (95 percent confidence interval, 0.75 to 2.43); the odds ratio adjusted for confounders was 1.42 (95 percent confidence interval, 0.72 to 2.80). An IgG anticardiolipin level of 5 units or more was found in 4 case patients (1.2 percent) and 15 controls (1.5 percent). The crude and adjusted odds ratios for fetal loss were 0.80 (95 percent confidence interval, 0.26 to 2.41) and 1.28 (95 percent confidence interval, 0.38 to 4.21), respectively. CONCLUSIONS. There is not apparent justification for considering lupus anticoagulants or IgG anticardiolipins to be risk factors for fetal loss among women who present with spontaneous abortion or fetal death and have had no previous spontaneous fetal loss.

Source Information

Department of Community Health, Hopital Sainte-Justine, Universite de Montreal, Quebec, Canada.

This article has been cited by other articles:

• Nielsen, H. S., Christiansen, O. B. (2005). Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant. Hum Reprod 20: 1720-1728 [Abstract] [Full Text]  
• Gris, J.-C., Perneger, T. V., Quere, I., Mercier, E., Fabbro-Peray, P., Lavigne-Lissalde, G., Hoffet, M., Dechaud, H., Boyer, J.-C., Ripart-Neveu, S., Tailland, M.-L., Daures, J.-P., Mares, P., Dauzat, M. (2003). Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study. Blood 102: 3504-3513 [Abstract] [Full Text]  
• Infante-Rivard, C., Rivard, G.-E., Gauthier, R., Theoret, Y. (2003). Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction. Clin. Chem. 49: 1476-1482 [Abstract] [Full Text]  
• Lee, R. M., Brown, M. A., Branch, D. W., Ward, K., Silver, R. M. (2003). Anticardiolipin and Anti-{beta}2-Glycoprotein-I Antibodies in Preeclampsia. Obstet Gynecol 102: 294-300 [Abstract] [Full Text]  
• Infante-Rivard, C., Rivard, G.-E., Yotov, W. V., Genin, E., Guiguet, M., Weinberg, C., Gauthier, R., Feoli-Fonseca, J. C. (2002). Absence of Association of Thrombophilia Polymorphisms with Intrauterine Growth Restriction. NEJM 347: 19-25 [Abstract] [Full Text]  
• DREYFUS, M., HEDELIN, G., KUTNAHORSKY, R., LEHMANN, M., VIVILLE, B., LANGER, B., FLEURY, A., M'BAREK, M., TREISSER, A., WIESEL, M.-L., PASQUALI, J.-L. (2001). Antiphospholipid Antibodies and Preeclampsia: A Case-Control Study. Obstet Gynecol 97: 29-34 [Abstract] [Full Text]  
• Kupferminc, M. J., Eldor, A., Steinman, N., Many, A., Bar-Am, A., Jaffa, A., Fait, G., Lessing, J. B. (1999). Increased Frequency of Genetic Thrombophilia in Women with Complications of Pregnancy. NEJM 340: 9-13 [Abstract] [Full Text]  
• Ogasawara, M., Aoki, K., Matsuura, E., Sasa, H., Yagami, Y. (1996). Anti {beta}2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance. Lupus 5: 587-592 [Abstract]  
• Barbui, T., Finazzi, G. (1994). Clinical Trials on Antiphospholipid Syndrome: What is Being Done and What is Needed?. Lupus 3: 303-307  
• Vlachoyiannopoulos, P. G., Karassa, F. B., Karakostas, K. X., Drosos, A. A., Moutsopoulos, H. M. (1993). Systemic Lupus Erythematosus in Greece. Clinical Features, Evolution and Outcome: a Descriptive Analysis of 292 Patients. Lupus 2: 303-312 [Abstract]